12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks showed notable movements. Orgenesis, AN2 Therapeutics, GRI Bio, NuCana, Stoke Therapeutics, and Candel Therapeutics were among the gainers, with increases ranging from 4.99% to 8.5%. On the downside, Acorda Therapeutics, Aesthetic Medical Intl, Eiger BioPharmaceuticals, Coeptis Therapeutics, iSpecimen, and WAVE Life Sciences experienced declines between 4.96% and 8.9%. These movements reflect the dynamic nature of the healthcare sector in the stock market.
April 04, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acorda Therapeutics shares declined by 8.9% to $1.53, with a market cap of $1.9 million. Q4 earnings were released 3 days ago.
The decline in Acorda Therapeutics' stock price following its Q4 earnings release suggests a negative market reaction to the financial results, potentially leading to short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
AN2 Therapeutics shares rose by 6.76% to $3.47, with a market cap of $103.3 million.
The increase in AN2 Therapeutics' shares suggests investor optimism, possibly due to recent company developments or market conditions favoring the healthcare sector.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Orgenesis shares increased by 8.5% to $0.63, with a market cap of $21.4 million.
The significant increase in Orgenesis' stock price may indicate positive investor sentiment or reaction to company-specific news, potentially leading to short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90